QA: GlobeStar Therapeutics Corp in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2019_GlobeStar_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001502152')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001502152, GlobeStar Therapeutics Corp

  xvar xval
0 AssetsCurrent 111,807
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,294
3 remainder_Assets 11,644
4 LiabilitiesCurrent 995,476
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 207
8 SellingGeneralAndAdministrativeExpense 351,735
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 103,490
11 remainder_Revenues 6,421
12 remainder_NetIncome -367,730
13 remainder_ComprehensiveNetIncome 1,941
  yvar yval
0 Assets 124,745
1 Liabilities 995,476
2 Expenses 455,432
3 Revenues 6,421
4 StockholdersEquity -870,731
5 NetIncome -816,741
6 ComprehensiveNetIncome -815,770
7 BaseVar 975,872
8 EconomicCapitalRatio -4.13

Edgar->Model Mapping

Feature Distribution

Change over Time